BioTime Will Have to Compete for California Cash for Geron’s Dormant Clinical Trial
By Dr. Matthew Watson
The California stem cell agency said
today it does not plan to reactivate the $25 million loan to assist
in Geron's spinal injury clinical trial despite an impending deal that would turn the effort over to BioTime, Inc.
public communications for the agency, said BioTime will have to
compete in an upcoming award round if it wants to win California
dollars.
California Stem Cell Report, McCormack said,
“That (earlier) loan was specific to
Geron and when the trial was ended the loan ended too. Of course if
Biotime and Geron do complete their deal then Biotime would be free
to apply to us for a new disease team grant.”
could also compete in other appropriate rounds, including the
strategic partnership round just posted by CIRM. It provides for four
awards of up to $15 million. Funding could come as early as October
of next year. The strategic partnership round is a business-friendly
effort that is aimed at attracting “industry engagement and
investment.” The deadline for letters of intent is Dec. 18.
million loan to Geron in 2011 just a few months before the Menlo Park
firm abandoned its human embryonic stem cell trial for financial
reasons. (The full text of the loan agreement can be found here.) The company has repaid the loan with interest.
assets associated with the clinical trial since last November. The only public
interest that has surfaced has come from BioTime, Inc., of Alameda,
Ca. Michael West, founder of Geron, is the CEO of BioTime. Tom
Okarma, CEO of Geron from 1999 to 2011, is CEO of the BioTime
subsidiary that would assume the clinical trial.
be published soon, according to a story in the San Francisco Business
Times by Ron Leuty. He quoted CIRM President Alan Trounson as saying
that “some findings” from the trial would be published next month
in a medical journal.
time of this writing today, up from $1.21 yesterday. BioTime's stock
stood at $2.99, up from $2.97.
Source:
http://feedproxy.google.com/~r/blogspot/uqpFc/~3/DS-6n2DoRy0/biotime-will-have-to-compete-for.html
Geron, BioTime Deal Moves Forward with Letter of Intent
By Dr. Matthew Watson
Geron Corp., which once pioneered human
embryonic stem cell research, is close to selling off its hESC business in a complicated deal involving two former CEOs of the company and
BioTime, Inc., of Alameda, Ca.
announced a “letter of intent” involving a transaction in which
BioTime would acquire the assets of Geron's hESC clinical trial that
the company suddenly abandoned last year. The firm also laid off 66 people,
about 40 percent of its staff.
few months after the $3 billion California stem cell agency loaned Geron $25 million to assist in the trial. The agency could
restore the loan for the trial, but the Geron-BioTime announcement
did not mention that possibility. The California Stem Cell Report has
asked the agency for comment.
one day after Geron announced that it was giving up the hESC spinal injury trial because of financial reasons. The Menlo Park, Ca., firm
has been trying to sell its hESC assets since then. BioTime has
been the only firm to express public interest. The Geron trial was
the first hESC trial approved by the FDA.
West, who founded Geron and is now head of Biotime, and Tom Okarma,
who was CEO of Geron from 1999 to 2011. Okarma is now head of BioTime
Acquisition Corp.,(BAC) a subsidiary of BioTime.
described the deal in which BioTime would acquire Geron's
“intellectual property and other assets related to Geron’s
discontinued human embryonic stem cell programs.”
“ BioTime would contribute
to BAC $5 million in cash, $30 million of BioTime common
shares, warrants to purchase eight (8) million common shares
of BioTime at a pre-specified price, rights to use certain
human embryonic stem cell lines, and minority stakes in two of
BioTime’s subsidiaries. In addition, a private investor would
invest $5 million in cash in BAC.
“Following consummation of the
potential transaction, Geron stockholders would receive
shares representing 21.4% of the common stock of BAC as well as
warrants to purchase 8 million shares of BioTime common
stock at a pre-specified price. BioTime would own
approximately 71.6%, and a private investor would own approximately
7.0% of the outstanding BAC common stock for their $5
million investment. BioTime would also receive
warrants that would enable it to increase its ownership in BAC by
approximately 2%, which would reduce the Geron stockholders’
ownership in BAC to 19.2%. BAC would also be committed to pay
to Geron royalties on the sale of products that are
commercialized in reliance upon Geron patents acquired by
BAC.”
intent, an article earlier this week by Vickie Brower in The Scientist said,
“The offer couldn’t come at a
better time for Geron, which in recent months has started to feel
pressure from its shareholders to boost its stock price and move
products through the pipeline. Since last November, when the company
announced its decision to shutter its hESC and regenerative medicine
business and funnel its resources into developing telomerase-related
treatments for cancer, the stock price has dropped more than 50
percent to $1.30 a share. Geron claimed the move was simply to save
money, but many took the decision—which effectively terminated a
clinical trial of an hESC treatment for spinal cord injury—as a
setback for the entire field."
News coverage of yesterday's
announcement was light. Here is a link to a piece by Ryan McBride on
Fierce Biotech.
yesterday and rose to $1.24 in after hours trading. BioTime closed at
$2.97. No after hours trading was reported for BioTime.
Bone Marrow Stem cells for Rotator cuff Injury – Video
By raymumme
Bone Marrow Stem cells for Rotator cuff Injury
George Ramsey Describes the road to recovery of his shoulder function using his own bone marrow stemcellsFrom:FLRegenerativeMedViews:0 0ratingsTime:01:55More inEducation
Read the rest here:
Bone Marrow Stem cells for Rotator cuff Injury - Video
Stem Cell Therapy | Stem Cell Malaysia – Video
By daniellenierenberg
Stem Cell Therapy | Stem Cell Malaysia
stemcellmalaysia.com Stem cell therapy is a form of cell therapy that makes use of stem cells harvested from placenta for disease treatment. Stem cell therapy is also used for beauty, anti-aging and health rejuvenation purposes. The efficacy of stem cell therapy has been in practice for decades. Many rich and wealthy individuals and celebrities pay hefty price for stem cell therapy just to maintain youthfulness and vitality. For many severely ill-stricken people who have exhausted all means of conventional therapy look toward stem cell therapy for saving their condition and life. stemcellmalaysia.comFrom:stemcells2012Views:224 2ratingsTime:07:23More inHowto Style
Read the rest here:
Stem Cell Therapy | Stem Cell Malaysia - Video
Mrs. Linda Flournoy – Video
By daniellenierenberg
Mrs. Linda Flournoy
describes ger experience with Stem Cell Therapy PRPFrom:FLRegenerativeMedViews:2 0ratingsTime:02:27More inEducation
Read more:
Mrs. Linda Flournoy - Video
MS Journey – Adult Stem Cells Progress.wmv – Video
By daniellenierenberg
MS Journey - Adult Stem Cells Progress.wmv
Breif interview of my progress with Multiple Sclerosis with Adult Stem Cell therapy after my experience with Tysabri, Gilenya and Ampira..From:MSajourneyfromwithinViews:0 0ratingsTime:04:21More inEducation
See the original post here:
MS Journey - Adult Stem Cells Progress.wmv - Video
The cell therapist
By LizaAVILA
For Dr. Robert Janson-Mller, the science of fresh cell therapy is in his blood.
His grandfather, Dr. Philipp Janson was one of the few doctors who introduced the treatment in Germany. His father, Dr. Wolfgang Janson-Mller continued the work that was eventually passed on to him.
He was exposed to the revolutionary world of fresh cell therapy early on in life. The treatment uses live young cells from a donor animal like sheep to help regenerate damaged cells in the body. Dr. Mller practically grew up in his grandfather and father's clinic where he met the former's patients, some of whom still go to him for their regular treatments.
''A child always wants to grow up like his father and do the same thing. My father left it open for me. He told me I could do whatever I want, the same thing I am doing now for my daughter. I'm also head of a clinic in Munich. This is what I do besides cell treatment. We have a family practice. That is my main job,'' shares the 46-year-old German doctor who recently visited the Philippines to acquaint Filipinos with the science of fresh cell therapy.
Dr. Mller, who owns a fresh cell therapy laboratory and works as head doctor of Med Activ clinic in Munich, says that despite the growing market for it in America and Asia, there are only five doctors in Germany practicing the science. The treatment is known to deter degenerative diseases such as arthrosis, rheumatism and neurological disorders such as multiple sclerosis. But it is most popular as an anti-aging treatment. Recently, it has also been used to treat children with autism and Down syndrome.
Yet, Dr. Mller points out that fresh cell therapy is not a miracle cure for aging or these diseases. Some bodies accept the treatment while some don't. And, it doesn't treat every disease known to mankind.
Nevertheless, patients from all over the world still flock to his private clinic at the Prinzregent Hotel in Edenkoben, Germany to avail themselves of the treatment, which does not come cheap. One session would cost about $12,000 or R624,000.
''I don't treat patients with cancer, tuberculosis, AIDS, or those who are pregnant. We don't treat patients with acute inflammations like appendicitis. Aside from that, I need to see if it makes sense. If I don't see a possibility, I say no,'' he explains.
In this 60 Minutes interview, Dr. Mller shares how fresh cell therapy really works and how it can take more than just one, two, 20, 60 or even 100 treatments to get it right. Some may start as young as eight months old or continue the treatment at 99 years old. This just proves that a patient is never too young nor too old for this revolutionary treatment. (Angelo G. Garcia)
STUDENTS AND CAMPUSES BULLETIN (SCB): A lot of people are confused about the difference between stem cell and fresh cell therapy.
Continue reading here:
The cell therapist
Jill Helms, "Forever Young: The New Frontier of Stem Cell Medicine" – Video
By LizaAVILA
Jill Helms, "Forever Young: The New Frontier of Stem Cell Medicine"
The good part about getting older is that we gain some wisdom and patience. The bad part is that our bodies start to wear out. But what if we could revitalize our damaged bits back to a healthy state? Come hear what the field of Regenerative Medicine is striving to achieve, and learn how it all begins with the stem cell. Jill Helms is a professor in Plastic and Reconstructive Surgery in the department of surgery at Stanford University #39;s School of Medicine. This Classes Without Quizzes lecture was filmed on location at Stanford Reunion Homecoming 2012 by the Stanford Alumni Association.From:StanfordAlumniViews:11 0ratingsTime:54:05More inEducation
Follow this link:
Jill Helms, "Forever Young: The New Frontier of Stem Cell Medicine" - Video
Stem Cells, FDA, Legal and Regulated elsewhere.mov – Video
By Sykes24Tracey
Stem Cells, FDA, Legal and Regulated elsewhere.mov
Rejuvenare on stem cell therapy, not approved by the FDA in the United States but legal and regulated in other countries.From:rejuvenareViews:0 0ratingsTime:00:23More inEducation
See the rest here:
Stem Cells, FDA, Legal and Regulated elsewhere.mov - Video
Rejuvenare – I don’t have time to wait for approval in the US – Video
By LizaAVILA
Rejuvenare - I don #39;t have time to wait for approval in the US
Patient Jerry relates why he chose Rejuvenare stem cell therapy to treat Parkinson #39;s outside the US. Although he #39;d earlier been successful keeping the disease #39;s progression slowed, they were no longer effective for him and he was told it would be about 10 years before this procedure was approved in the USFrom:rejuvenareViews:0 0ratingsTime:01:24More inEducation
The rest is here:
Rejuvenare - I don't have time to wait for approval in the US - Video
Rejuvenare stem cell treatment for stroke.mov – Video
By Sykes24Tracey
Rejuvenare stem cell treatment for stroke.mov
Rejuvenare CEO Carlo Velarde relates how his mother, completely incapacitated by a crippling stroke, has regained her quality of life, her mobility, her thought process after undergoing stem cell therapy for stroke.From:rejuvenareViews:0 0ratingsTime:00:47More inEducation
Read the rest here:
Rejuvenare stem cell treatment for stroke.mov - Video
The Rejuvenare Experience .mov – Video
By JoanneRUSSELL25
The Rejuvenare Experience .mov
Patient Jerry and his wife discuss their Rejuvenare experience in Jerry receiving stem cell therapy for Parkinson #39;s disease. They are very impressed with how fantastic the experience has been and wonders how Rejuvenare can offer such excellent services to its patient clients.From:rejuvenareViews:0 0ratingsTime:01:11More inEducation
More here:
The Rejuvenare Experience .mov - Video
VCARE STEM CELL THERAPY – Video
By JoanneRUSSELL25
VCARE STEM CELL THERAPY
Vcare has launched two treatments options based on stem cell products, one for diffused alopecia, the reversible form of hair loss and one for Androgenetic alopecia, commonly called as "Baldness".From:VCare TrichologyViews:1 0ratingsTime:04:36More inHowto Style
The rest is here:
VCARE STEM CELL THERAPY - Video
David Kekich – Stem Cell Therapy Breakthrough – Video
By JoanneRUSSELL25
David Kekich - Stem Cell Therapy Breakthrough
Centagen is developing technology to help millions of people who suffer from chronic pain, disease and injury with an advanced form of adult stem cell therapy. For more information go to http://www.indiegogo.comFrom:CentagenViews:187 80ratingsTime:02:35More inScience Technology
See the original post:
David Kekich - Stem Cell Therapy Breakthrough - Video
The Princess Margaret BMT Program Chooses Remedy Informatics’ Blood and Marrow Transplant & Cell Therapy Solutions to …
By NEVAGiles23
Princess Margaret Cancer Program will implement ComprehensiveBMT and Investigate Cell Therapy to continue leading role in cancer care and research
SALT LAKE CITY , Nov. 14, 2012 /CNW/ - Remedy Informatics, the leading provider of registries and research informatics software for Life Science and Translational Research and Healthcare, today announced the Princess Margaret Cancer Centre at University Health Network in Toronto has selected ComprehensiveBMT and Investigate Cell Therapy, two of Remedy's innovative clinical informatics solutions.
(Logo: http://photos.prnewswire.com/prnh/20120206/SF47874LOGO)
"The Princess Margaret is one of the largest comprehensive cancer facilities in the world with the largest Blood and Marrow Transplant program in Canada and a gold standard cancer research facility," said Gary Kennedy , Founder and CEO of Remedy Informatics. "Both InvestigateCT and ComprehensiveBMT offer unmatched integration of information to improve treatment outcomes by aggregating, mapping, harmonizing and analyzing data across clinical and scientific disciplines. Valuable information will give valuable insights into patient safety, patient survivorship, and quality improvement for transplant physicians, nurses and researchers."
Built on Remedy's flagship Mosaic Platform, InvestigateCT and ComprehensiveBMT offer the Princess Margaret the world's first and only truly integrated research management system. In addition to combining blood and marrow registries with cell therapy laboratories and biobanks, clinicians and researchers will have an unprecedented view of their data through the Mosaic Ontology, which aggregates, maps and harmonizes the data to facilitate pattern recognition. Together researchers are able to manage and aggregate more data sources, across disciplines, including next-generation sequencing, cross-disease registries, LIMS and the Blood and Marrow Transplant Program to advance research of cell therapies, blood and marrow transplantation, and related diseases.
"The future of patient care and innovative research in blood and marrow transplantation requires rapid data analysis to track and improve patient outcomes. We are confident Remedy Informatics can meet our needs," said Dr. John Kuruvilla , MD, FRCP(C), director, Clinical Program, Blood and Marrow Transplant program at the Princess Margaret . "We foresee better information management as the cornerstone for improving patient outcomes in hematologic malignancies."
The Princess Margaret BMT program has an international reputation as a global leader in clinical and research programs and as a gold standard in transplant technologies like Apheresis collections for peripheral stem cell transplant infusions and Extracorporeal Photopheresis for selected graft-vs-host conditions. Over the next year, Remedy will work with the Princess Margaret BMT program to implement InvestigateCT, the world's first Integrated Research Management System designed for cancer centers involved in clinical research using cell therapies. InvestigateCT will facilitate multi-directional data flow throughout the BMT program, cell therapy labs and biobanks to improve real-time analytics, therapies, patient safety, and quality across the transplant care pathway as well as long-term patient survivorship for patients who are living longer and healthier lives.
Remedy serves a wide range of leading Life Science and Translational Research institutions across the country, including the Huntsman Cancer Institute at the University of Utah, Cleveland Clinic's Bariatric and Metabolic Institute and Heart and Vascular Institute, the American Joint Replacement Registry, Baylor Health Care System, and many more.
For more information about Investigate Cell Therapy or ComprehensiveBMT, or Remedy's leading patient registry technology, please visit our website, http://www.remedyinformatics.com. InvestigateCT is for research use only and is not intended for clinical or cell processing purposes.
About Remedy Informatics, Inc.
Original post:
The Princess Margaret BMT Program Chooses Remedy Informatics' Blood and Marrow Transplant & Cell Therapy Solutions to ...
Ageless Derma Formulates Apple Stem Cells into Anti-Wrinkle Cream with PhytoCellTec Technology
By raymumme
ANAHEIM, Calif., Nov. 13, 2012 /PRNewswire/ --A step ahead of the colossal skincare market, Ageless Derma, an innovative, anti-aging skincare company, leads its competition as the first to integrate the latest technology, PhytoCellTec. This cutting-edge technology cultivates stem cells from a rare apple and when incorporated into the Ageless Derma Stem Cell and Peptide Anti-Wrinkle cream, has proven to diminish wrinkles with exceptional results.
Patent pending, PhytoCellTec Malus Domestica is a liposomal preparation of apple stem cells designed to protect skin stem cells. Known for minimal shriveling and extended longevity, the Uttwiler Spalauber apple is rich in proteins, phytonutrients, and long-living cells. PhytoCellTec Malus Domestica is a scientifically proven breakthrough that effectively combats skin aging.
"We were excited to find new, revolutionary stem cell technology," said Dr. Farid Mostamand, owner and founder of the Ageless Derma skincare line. "This extraordinary process is a leap forward. Our customers want non-surgical options to fight wrinkles and sagging skin and PhytoCellTec technology provides exactly that. This has produced remarkable results for eliminating wrinkles so we integrated it into our Ageless Derma anti-wrinkle cream."
Pioneered by Mibelle BioChemistry Group, the founding company hosts scientific studies to substantiate claims that PhytoCellTec Malus Domestica provides revolutionary skin rejuvenation. Honored with the BSB Innovation Award in 2008 for best ingredient, Mibelle BioChemistry Group developed PhytoCellTec technology to enable plant stem cells to grow in considerable numbers. In comprehensive studies the company was able to prove PhytoCellTecMalus Domestica, the dynamic ingredient derived from the apple stem cells, supports longevity and vitality of skin stem cells.
In a study of volunteers ranging in age from 37 to 64, 100% of the subjects showed significant decreases in wrinkle depth. The volunteers applied a concentration of 2% PhytoCellTec Malus Domestica twice daily for 28 days to "crow's feet," or wrinkles near the eyes, to diminish wrinkles.
PhytoCellTec enables the cultivation of stem cells by using the same repair methods plant cells use. The PhytoCellTec process selects a diminutive piece of plant material which is then damaged to result in callus formation. The formations are incubated and harvested in order to obtain stem cells.
"Along with this miraculous stem cell factor, our anti-aging creams have other effective, safe ingredients such as vitamins, minerals, and peptides. Peptides also play a big role in our anti-wrinkle creams as they stimulate collagen growth to keep skin looking young," said Dr. Mostamand.
About Ageless Derma:
Ageless Derma is accredited with the Better Business Bureau and offers a 30-day money-back guarantee. Ageless Derma products are available at Focus Medical Spa in Anaheim, CA, through the website http://www.agelessderma.com, or toll-free (877) 777-1940. For more information on Ageless Derma, please contact Dr. Farid Mostamand at mostamand5@gmail.com or call (877) 777-1940.
Contact
More here:
Ageless Derma Formulates Apple Stem Cells into Anti-Wrinkle Cream with PhytoCellTec Technology
What Are Stem Cells | Stem Cell Malaysia – Video
By LizaAVILA
What Are Stem Cells | Stem Cell Malaysia
stemcellmalaysia.com Stem cells are non-differentiated cells with the ability to divide and produce any body cell types. The ability of stem cells to differentiate and self-regenerate impart great possibilities for disease treatment other than for restoring health, beauty and anti-aging. Clinically proven for certain illness and conditions, stem cells can now be introduced into the body to repair and replace damaged organ or tissue. For more informative articles on stem cells and stem cell therapy, please visit Stem Cell Malaysia at http:/stemcellmalaysia.com/.From:stemcells2012Views:89 1ratingsTime:06:29More inHowto Style
See the article here:
What Are Stem Cells | Stem Cell Malaysia - Video
cord blood | Cord Blood Cells – Advantages Of Extracting Stem Cells From Umbilical Cord – Video
By Sykes24Tracey
cord blood | Cord Blood Cells - Advantages Of Extracting Stem Cells From Umbilical Cord
http://www.cordbloodrecommendation.com The real treatment takes place when the patient is infused with stem cells, which start producing white blood cells in order to make the amount of white blood cells reach the normal number. The nerve cells are known as the ""substantia nigra. Chronic Myelogenous Leukemia Chronic Lymphocytic Leukemia Juvenile Chronic Myelogenous Leukemia Hunter #39;s Syndrome Tay-Sachs Disease Wolman Disease Lesch-Nyhan Syndrome Osteoporosis Beta Thalassemia Major Samples of twin pregnancies were generally rejected due the low availability of cells. The banking facility helps in making blood donation readily available for transplantation #39;s. Flex blood caching can be lifesavers for your family too. She sought umbilical cord blood stem cell therapy from the private Preventative Medicine Clinic in the Netherlands. Stromal cells are a kind of cells that form bone, cartilage, fat, and fibrous connective tissue. Twenty-five children diagnosed with Krabbe #39;s disease were followed and studied regarding their treatments. The National Cord Blood Program staff at the New York Blood Center performs cord blood collection from the expelled placenta. Red blood cells, white blood cells and platelets develop from these cells. The phenomenon is growing fast and the situation is unclear. The blood needs to be collected within 10 to fifteen minutes of birth which is why arrangements must be made ahead of time. If they are able to grow sufficiently, the new cell will make new blood ...From:loshoteles enmedellinViews:0 0ratingsTime:01:18More inScience Technology
More here:
cord blood | Cord Blood Cells - Advantages Of Extracting Stem Cells From Umbilical Cord - Video
cord blood bank | Cheapest Cord Blood Banking – Video
By Sykes24Tracey
cord blood bank | Cheapest Cord Blood Banking
http://www.cordbloodrecommendation.com Cord blood will be the right answer for some diseases. One case is that of Stephen Sprague who was diagnosed with Chronic Myelogenous Leukemia (CML) in 1995. Once you catalog with a cord blood cache, they forward you a kit, containing all the crucial gear for collecting cord blood, along with instructions for the presence doctor, imparter or attention employees. As a parent, we have a choice. It will be easier to take advantage of these new possibilities if you have your own cord blood available for use. She sought umbilical cord blood stem cell therapy from the private Preventative Medicine Clinic in the Netherlands. Another practical application of storing umbilical cord blood after birth is that it can be used for cardiovascular diseases. Everybody, right from the parents to the obstetrician, and the concerning blood bank has to be ready for storage before the baby is born. Why? Because, they say, a public pool to draw on is considerably larger than having a single source of blood. A courier from the stem cell bank will come and retrieve the collection kit and transport for processing and storage. If you can afford to harvest and store your newborns cord blood by all means does so. Although only about 2 cups of cord blood can be collected from the umbilical cord at birth, this small amount is rich in these early (primitive) cells. The closer the blood relation of the cell donor means the more likely that these cells will be helpful. On ...From:luisantafeViews:0 0ratingsTime:01:18More inScience Technology
View post:
cord blood bank | Cheapest Cord Blood Banking - Video
umbilical cord blood | Cord Blood – Life Saving Out of the Womb – Video
By raymumme
umbilical cord blood | Cord Blood - Life Saving Out of the Womb
http://www.cordbloodrecommendation.com The collected blood should be processed by specialists in the laboratory within 48 hours and stored properly. Stems cells are very important. Again, these are not hard and fast numbers but just estimates. This procedure also supplies a rapid chromosome analysis within high levels of accuracy. As we all know that it is rich in Hematopoietic stem cells. Extracting bone marrow is a very painful and difficult procedure, and if you have your own blood, then you do not need to make your family members go through the bone marrow transplant procedure. If your child is able to pass the pre-screening process, the program has been highly regarded and is an excellent, free alternative to private registry. Preserved stem cells are used when the body is in a weakened state from disease or treatments such as chemotherapy. Cord blood stem cell therapy has regenerative characteristics. This kind of disease typically attacks the neurons of the central nervous system in the brain. If they decide to donate to a public facility, there are no storage fees however because of privacy concerns all identification features are removed from that particular storage lot within a few years. How many years can a baby #39;s cord blood be saved?Cord blood banking is a relatively new concept. If they are able to grow sufficiently, the new cell will make new blood cells. If you have stem cells of your child, then you will not even need to find bone marrow donors in case your child isFrom:Implantes DentalesViews:0 0ratingsTime:01:18More inScience Technology
See the original post here:
umbilical cord blood | Cord Blood - Life Saving Out of the Womb - Video